logo

External Quality Control Testing (for Cellular and Molecular Therapies)

The scope, dates and status of this tender. A free account opens every field.

Source: Open Contracting Data Standard (OCDS)

Tender
Planning

NHS Blood and Transplant is seeking to engage with the market in relation to the provision of external Quality Control testing services to support the Clinical Biotechnology Centre in the development and production of Advanced Therapeutic Investigational Medicinal Products, biotechnology products and biological products. The requirement is expected to include specialist QC testing services for in-

Status
Prospective
Location
United Kingdom
Updated
3 Nov 2026
Source
Open Contracting Data Standard (OCDS)

ConstructChat

Ask ConstructChat about External Quality Control Testing (for Cellular and Molecular Therapies)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “External Quality Control Testing (for Cellular and Molecular Therapies)” is a tender record in Taiyo. It is issued for works, goods, or services related to United Kingdom.

Participants

Not available for this record.

Status

Original status

planning

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

NHS Blood and Transplant is seeking to engage with the market in relation to the provision of external Quality Control testing services to support the Clinical Biotechnology Centre in the development and production of Advanced Therapeutic Investigational Medicinal Products, biotechnology products and biological products. The requirement is expected to include specialist QC testing services for in-process, final product and cell bank testing, with testing capabilities potentially including mycoplasma testing, bacterial cell bank testing, mammalian cell bank testing, specialised viral safety testing, viral clearance studies, sterility testing and cell-based sterility testing. The precise testing requirements may vary by project and NHSBT may require the ability to add or remove tests during the contract term. Suppliers would be expected to operate under appropriate regulatory and quality standards, including GMP and, where applicable, GLP, and to provide validated assays, appropriate quality documentation, Certificates of Analysis, comprehensive reports, support for quality technical agreements, audit access and out of specification investigations.

Location

Country

United Kingdom (UK)

Source

Source

Open Contracting Data Standard (OCDS)

URL

More Details

Record type

Tender

Article published date

2026-08-02

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender